Interactions Between Plasma Amyloid and Aging Markers to Determine Clinically Meaningful Cognitive Decline

Background: Brain amyloidosis is a well-known pathological hallmark of Alzheimer’s disease (AD) and can be early identified by measuring plasma amyloid-β (Aβ) status. Growing evidence implicates the biological mechanisms of aging, including chronic inflammation, mitochondrial dysfunction and neurode...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wan-Hsuan, Giudici, Kelly, Vellas, Bruno, de Barreto, Philipe Souto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681056/
http://dx.doi.org/10.1093/geroni/igab046.2607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681056/
http://dx.doi.org/10.1093/geroni/igab046.2607

Ejemplares similares